SNO 2018: Dendritic Cell Vaccine Pulsed With Lysate Derived From an Allogeneic GBM Stemlike Cell Line Shows Promise
Extended time to progression and overall survival were observed in both newly diagnosed and recurrent GBM.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.